ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

wockhardt bio pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; sodium citrate; water for injections; citric acid monohydrate; sodium hydroxide - oxycodone wockhardt is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

wockhardt bio pty ltd - oxycodone hydrochloride, quantity: 10 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; citric acid monohydrate; water for injections; sodium chloride; sodium hydroxide; sodium citrate - oxycodone wockhardt is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

eisai (singapore) pte. ltd. - dimethyl fumarate - capsule, enteric coated - dimethyl fumarate 120.0mg

सिंगापुर - अंग्रेज़ी - HSA (Health Sciences Authority)

eisai (singapore) pte. ltd. - dimethyl fumarate - capsule, enteric coated - dimethyl fumarate 240.0 mg

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

teva b.v. - fingolimod - capsule, hard - 0.5 milligram(s) - fingolimod

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

norton waterford - fingolimod - capsule, hard - 0.5 milligram(s) - fingolimod

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - dimethyl fumarate, quantity: 240 mg - capsule, enteric - excipient ingredients: croscarmellose sodium; gelatin; purified talc; magnesium stearate; iron oxide yellow; silicified microcrystalline cellulose; triethyl citrate; titanium dioxide; brilliant blue fcf; methacrylic acid copolymer; colloidal anhydrous silica; iron oxide black; methacrylic acid - ethyl acrylate copolymer (1:1); propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - dimethyl fumarate enteric coated capsules are indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - dimethyl fumarate, quantity: 120 mg - capsule, enteric - excipient ingredients: croscarmellose sodium; gelatin; purified talc; magnesium stearate; iron oxide yellow; silicified microcrystalline cellulose; triethyl citrate; titanium dioxide; brilliant blue fcf; methacrylic acid copolymer; colloidal anhydrous silica; iron oxide black; methacrylic acid - ethyl acrylate copolymer (1:1); propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; potassium hydroxide - dimethyl fumarate enteric coated capsules are indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - fingolimod - capsule, hard - 0.5 milligram(s) - fingolimod

आयरलैंड - अंग्रेज़ी - HPRA (Health Products Regulatory Authority)

alfred e tiefenbacher (gmbh & co. kg) - fingolimod - capsule, hard - 0.5 milligram(s) - fingolimod